Fig. 3From: Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)6 potential non-approved HDACis for PTCL. These potential HDACis remaining non-approved and not acquiring comprehensive clinical evaluation in PTCLBack to article page